Filing Details
- Accession Number:
- 0001209191-10-025148
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-05-04 13:00:00
- Reporting Period:
- 2010-04-30
- Filing Date:
- 2010-05-04
- Accepted Time:
- 2010-05-04 17:31:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1107332 | Dendreon Corp | DNDN | Pharmaceutical Preparations (2834) | 223203193 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1242879 | David Urdal | 3005 First Avenue Seattle WA 98121 | Svp, Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-04-30 | 32,268 | $53.93 | 651,992 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-04-30 | 7,732 | $53.93 | 644,260 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Billionaire Hedge Funds
